| New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 491 | 2022 |
| A midline switch of receptor processing regulates commissural axon guidance in vertebrates H Nawabi, A Briançon-Marjollet, C Clark, I Sanyas, H Takamatsu, ... Genes & development 24 (4), 396-410, 2010 | 155 | 2010 |
| Systemic and central nervous system metabolic alterations in Alzheimer’s disease V van der Velpen, T Teav, H Gallart-Ayala, F Mehl, I Konz, C Clark, ... Alzheimer's Research & Therapy 11, 1-12, 2019 | 131 | 2019 |
| Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ... Nature communications 12 (1), 3417, 2021 | 129 | 2021 |
| Axon guidance in the developing ocular motor system and Duane retraction syndrome depends on Semaphorin signaling via alpha2-chimaerin JE Ferrario, P Baskaran, C Clark, A Hendry, O Lerner, M Hintze, J Allen, ... Proceedings of the National Academy of Sciences 109 (36), 14669-14674, 2012 | 56 | 2012 |
| An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer’s disease C Clark, L Dayon, M Masoodi, GL Bowman, J Popp Alzheimer's research & therapy 13 (1), 1-19, 2021 | 53 | 2021 |
| Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression C Clark, P Lewczuk, J Kornhuber, J Richiardi, B Maréchal, TK Karikari, ... Alzheimer's research & therapy 13 (1), 1-11, 2021 | 49 | 2021 |
| Parvalbumin-interneuron output synapses show spike-timing-dependent plasticity that contributes to auditory map remodeling ED Vickers, C Clark, D Osypenko, A Fratzl, O Kochubey, B Bettler, ... Neuron 99 (4), 720-735. e6, 2018 | 41 | 2018 |
| α2-Chimaerin regulates a key axon guidance transition during development of the oculomotor projection C Clark, O Austen, I Poparic, S Guthrie Journal of Neuroscience 33 (42), 16540-16551, 2013 | 31 | 2013 |
| Factors associated with subjective cognitive decline in dementia‐free older adults—A population‐based study L Zullo, C Clark, M Gholam, E Castelao, A von Gunten, M Preisig, J Popp International Journal of Geriatric Psychiatry 36 (8), 1188-1196, 2021 | 23 | 2021 |
| Cholesterol metabolites and plant sterols in cerebrospinal fluid are associated with Alzheimer’s cerebral pathology and clinical disease progression T Jahn, C Clark, A Kerksiek, P Lewczuk, D Lütjohann, J Popp The Journal of steroid biochemistry and molecular biology 205, 105785, 2021 | 22 | 2021 |
| TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels S Hong, V Dobricic, O Ohlei, I Bos, SJB Vos, D Prokopenko, BM Tijms, ... Alzheimer's & Dementia 17 (10), 1628-1640, 2021 | 16 | 2021 |
| Cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate, Alzheimer’s disease pathology, and cognitive decline S Ouanes, C Clark, J Richiardi, B Maréchal, P Lewczuk, J Kornhuber, ... Frontiers in Aging Neuroscience 14, 2022 | 7 | 2022 |
| Role of BMP signaling for the formation of auditory brainstem nuclei and large auditory relay synapses E Kronander, C Clark, R Schneggenburger Developmental neurobiology 79 (2), 155-174, 2019 | 6 | 2019 |
| The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer’s disease C Clark, M Rabl, L Dayon, J Popp Frontiers in Aging Neuroscience 14, 1065904, 2022 | 5 | 2022 |
| Cerebrospinal fluid proteome alterations associated with neuropsychiatric symptoms in cognitive decline and Alzheimer’s disease M Mroczek, C Clark, L Dayon, GL Bowman, J Popp Cells 11 (6), 1030, 2022 | 5 | 2022 |
| LTP of inhibition at PV interneuron output synapses requires developmental BMP signaling E Vickers, D Osypenko, C Clark, Z Okur, P Scheiffele, ... Scientific Reports 10 (1), 1-12, 2020 | 5 | 2020 |
| Blood plasma protein profiles of neuropsychiatric symptoms and related cognitive decline in older people M Rabl, C Clark, L Dayon, GL Bowman, J Popp Journal of Neurochemistry 164 (2), 242-254, 2023 | 3 | 2023 |
| Persisting neuropsychiatric symptoms, Alzheimer’s disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate S Ouanes, M Rabl, C Clark, C Kirschbaum, J Popp Alzheimer's Research & Therapy 14 (1), 190, 2022 | 3 | 2022 |
| Systemic and central nervous system neuroinflammatory signatures of neuropsychiatric symptoms and related cognitive decline in older people C Clark, J Richiardi, B Maréchal, GL Bowman, L Dayon, J Popp Journal of Neuroinflammation 19 (1), 127, 2022 | 2 | 2022 |
